Identification of Serum and Urine Biomarkers of Type 1 Diabetes
The purpose of this study is to identify biomarkers (small molecules in the blood) that can predict those people at risk of developing Type 1 diabetes.
The purpose of this study is to develop and validate biomarkers that predict T1D disease risk and document disease progression based on blood or urine indicators of beta cell stress and death in emerging and establish T1D.
Participants will be compensated for their participation.
- IRB Number: 1411938757
- Research Study Identifier: TX4884
- Principal Investigator: Carmella Evans-Molina, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required